Posttranscriptional regulation of CD133 expression by microRNAs (miRNAs) has also been documented, and these findings are in line with CD133 expression in CSCs, as these short noncoding RNAs play important roles in cancer initiation and progression and in the control of signaling pathways activity [147, 148]. Here, PROM1 is linked to cancer.